178 related articles for article (PubMed ID: 22798209)
1. Aqueous seed extract of Syzygium cumini inhibits the dipeptidyl peptidase IV and adenosine deaminase activities, but it does not change the CD26 expression in lymphocytes in vitro.
Bellé LP; Bitencourt PE; Abdalla FH; Bona KS; Peres A; Maders LD; Moretto MB
J Physiol Biochem; 2013 Mar; 69(1):119-24. PubMed ID: 22798209
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of gallic acid and Syzygium cumini extract against oxidative stress-induced cellular injury in human lymphocytes.
De Bona KS; Bonfanti G; Bitencourt PE; da Silva TP; Borges RM; Boligon A; Pigatto A; Athayde ML; Moretto MB
Drug Chem Toxicol; 2016; 39(3):256-63. PubMed ID: 26364973
[TBL] [Abstract][Full Text] [Related]
3. Syzygium cumini seed extract ameliorates adenosine deaminase activity and biochemical parameters but does not alter insulin sensitivity and pancreas architecture in a short-term model of diabetes.
Bitencourt PE; Bona KS; Cargnelutti LO; Bonfanti G; Pigatto A; Boligon A; Athayde ML; Pierezan F; Zanette RA; Moretto MB
J Complement Integr Med; 2015 Sep; 12(3):187-93. PubMed ID: 25955284
[TBL] [Abstract][Full Text] [Related]
4. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients.
Bopp A; De Bona KS; Bellé LP; Moresco RN; Moretto MB
Fundam Clin Pharmacol; 2009 Aug; 23(4):501-7. PubMed ID: 19709327
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
6. Syzygium cumini is more effective in preventing the increase of erythrocytic ADA activity than phenolic compounds under hyperglycemic conditions in vitro.
De Bona KS; Bonfanti G; Bitencourt PE; Cargnelutti LO; da Silva PS; da Silva TP; Zanette RA; Pigatto AS; Moretto MB
J Physiol Biochem; 2014 Jun; 70(2):321-30. PubMed ID: 24407852
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
[TBL] [Abstract][Full Text] [Related]
9. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
10. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
[TBL] [Abstract][Full Text] [Related]
11. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
[TBL] [Abstract][Full Text] [Related]
12. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dipeptidyl peptidase-4 averts free fatty acids deposition in the hearts of oral estrogen-progestin contraceptive-induced hyperinsulinemic female rats.
Adegoke TE; Sabinari IW; Areola ED; Ajao F; Asafa OO; Soluoku TK; Bello A; Adesanmi AM; Yusuf SO; Omoleye A; Ayinla MT; Olatunji LA
Can J Physiol Pharmacol; 2021 Dec; 99(12):1316-1323. PubMed ID: 34310895
[TBL] [Abstract][Full Text] [Related]
14. Erythrocytic enzymes and antioxidant status in people with type 2 diabetes: beneficial effect of Syzygium cumini leaf extract in vitro.
De Bona KS; Bellé LP; Bittencourt PE; Bonfanti G; Cargnelluti LO; Pimentel VC; Ruviaro AR; Schetinger MR; Emanuelli T; Moretto MB
Diabetes Res Clin Pract; 2011 Oct; 94(1):84-90. PubMed ID: 21737173
[TBL] [Abstract][Full Text] [Related]
15. The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression.
Blanco J; Valenzuela A; Herrera C; Lluís C; Hovanessian AG; Franco R
FEBS Lett; 2000 Jul; 477(1-2):123-8. PubMed ID: 10899322
[TBL] [Abstract][Full Text] [Related]
16. Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult.
Chielle EO; Bonfanti G; De Bona KS; Moresco RN; Moretto MB
Clin Chem Lab Med; 2015 Jun; 53(7):1041-7. PubMed ID: 25527815
[TBL] [Abstract][Full Text] [Related]
17. Binding of adenosine deaminase to the lymphocyte surface via CD26.
De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
[TBL] [Abstract][Full Text] [Related]
18. Syzygium cumini extract decrease adenosine deaminase, 5'nucleotidase activities and oxidative damage in platelets of diabetic patients.
De Bona KS; Bellé LP; Sari MH; Thomé G; Schetinger MR; Morsch VM; Boligon A; Athayde ML; Pigatto AS; Moretto MB
Cell Physiol Biochem; 2010; 26(4-5):729-38. PubMed ID: 21063110
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-4 and adenosine deaminase enzyme levels in polycystic ovary syndrome.
Öztürk B; Gürbüz AS; Durak ZE; Öztürk HS
Gynecol Endocrinol; 2019 Feb; 35(2):138-141. PubMed ID: 30394149
[TBL] [Abstract][Full Text] [Related]
20. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
